Page last updated: 2024-10-24

carbazilquinone and Muscular Atrophy

carbazilquinone has been researched along with Muscular Atrophy in 1 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.

Research Excerpts

ExcerptRelevanceReference
"A striking chemotherapeutically curative effect on tumor was obtained by means of temporary interruption of regional blood flow combined with local hyperthermia."1.26Temporary interruption of regional blood flow combined with local hyperthermia for cancer chemotherapy. ( Aoki, K; Baba, T; Kanematsu, T; Kidera, Y; Kimura, M, 1976)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, T1
Aoki, K1
Kidera, Y1
Kimura, M1
Kanematsu, T1

Other Studies

1 other study available for carbazilquinone and Muscular Atrophy

ArticleYear
Temporary interruption of regional blood flow combined with local hyperthermia for cancer chemotherapy.
    Cancer research, 1976, Volume: 36, Issue:7 PT 1

    Topics: Animals; Antineoplastic Agents; Carbazilquinone; Carcinoma, Ehrlich Tumor; Chromomycins; Cyclophosph

1976